Our findings have a fundamental impact on therapeutic approaches toward mutant PIK3CA-bearing CRC cells, as TRAIL-induced pro-inflammatory signaling potentially fosters tumor formation and has been associated with increased invasiveness in vitro.9 Consequently, TRAIL-based therapies in this tumor entity may even be contraindicated unless TRAIL resistance can be efficiently overcome. This evidence concerns the gene PIK3CA and neoplasm.